Tumor cell imaging targeting KCa3.1? A feasibility study with labeled ligands
Kathrin Brömmel, pharmacist, Institute of Pharmaceutical and Medicinal Chemistry
Christian Paul Ortmeyer, chemist, Department of Nuclear Medicine
Import to own diary